Citation:Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al 2014

Citation

Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014 Dec;11(12):e1001764 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25460915.

Critical appraisals

• Assign a critical appraisal

Cited by

1. For patients undergoing workup for known or suspected lung cancer, what is the optimal timing of PET/CT? Before or after tissue biopsy confirmation?
2. Which population group would potentially most benefit from CT screening for lung cancer?